	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	26/03/2026
	www.isa.gov.il			www.tase.co.il				Reference:	2026-02-027773	Time of broadcast: 12:09 12:09

The corporation scheduled the publication of the report to 26/03/2026 14:30

Other Report or Announcement

Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

הנפקה פרטית לחברה בבעלות יו"ר הדירקטוריון

PR_Pluri_Inc_-_March_26_2026_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/08/2024
Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com Company site: www.pluristem.com

Previous names of reporting entity: PLURISTEM THERAPEUTICS INC

Name of the Signatory: Gal Hagit Position of Signatory in the reporting corporation: General Counsel & Corporate Secretary Name of Employer Company:
Address: Matam Park 5 , Haifa 3508409 Telephone: 074-7108600 Facsimile: 074-7107172 E-mail: legalnotices@pluri-biotech.com 1